HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo Bironzo Selected Research

Paolo Bironzo Research Topics

Disease

35Neoplasms (Cancer)
04/2024 - 04/2012
27Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2023 - 04/2012
11Lung Neoplasms (Lung Cancer)
01/2024 - 05/2018
7Mesothelioma
04/2024 - 11/2018
7Malignant Mesothelioma
03/2023 - 11/2018
4Adenocarcinoma of Lung
05/2023 - 01/2021
3Sarcoma (Soft Tissue Sarcoma)
01/2024 - 12/2014
3Brain Neoplasms (Brain Tumor)
12/2023 - 09/2023
3Neoplasm Metastasis (Metastasis)
12/2023 - 11/2020
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2023 - 02/2016
3Disease Progression
05/2021 - 02/2016
3Prostatic Neoplasms (Prostate Cancer)
01/2018 - 12/2013
2Adenocarcinoma
05/2023 - 04/2023
2Infections
01/2023 - 01/2020
2COVID-19
01/2022 - 01/2021
2Pleurisy (Pleuritis)
01/2021 - 01/2019
2Colorectal Neoplasms (Colorectal Cancer)
05/2018 - 01/2017
1Thrombosis (Thrombus)
01/2024
1Hepatitis B
01/2023
1Lung Diseases (Lung Disease)
08/2021
1Genetic Predisposition to Disease (Genetic Predisposition)
05/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Solitary Fibrous Tumors
01/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Synovial Sarcoma (Synovioma)
01/2021
1Fibroma (Fibromatosis)
01/2021
1Fasciitis (Fascitis)
01/2021
1Hyperplasia
01/2021
1Aggressive Fibromatosis (Desmoid)
01/2021
1Hemangiosarcoma (Angiosarcoma)
01/2021
1Leiomyosarcoma
01/2021
1Circulating Neoplastic Cells
12/2020
1Pulmonary Arterial Hypertension
01/2019

Drug/Important Bio-Agent (IBA)

18Immune Checkpoint InhibitorsIBA
01/2024 - 09/2017
8Biomarkers (Surrogate Marker)IBA
12/2023 - 01/2017
5Tyrosine Kinase InhibitorsIBA
12/2023 - 12/2014
4ErbB Receptors (EGF Receptor)IBA
12/2023 - 07/2012
4pembrolizumabIBA
10/2023 - 09/2019
4Cisplatin (Platino)FDA LinkGeneric
01/2023 - 04/2012
4Thymidylate SynthaseIBA
08/2022 - 01/2021
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2024 - 01/2021
3PlatinumIBA
12/2023 - 04/2012
3Anaplastic Lymphoma KinaseIBA
11/2023 - 12/2020
3B7-H1 AntigenIBA
08/2023 - 11/2020
3Pemetrexed (MTA)FDA Link
08/2022 - 11/2018
3DNA (Deoxyribonucleic Acid)IBA
07/2022 - 04/2012
3AsbestosIBA
05/2021 - 11/2018
3abirateroneIBA
01/2018 - 12/2013
2niraparibIBA
12/2023 - 01/2021
2dostarlimabIBA
12/2023 - 01/2021
2Programmed Cell Death 1 ReceptorIBA
08/2023 - 12/2014
2Messenger RNA (mRNA)IBA
01/2023 - 04/2012
2Proteins (Proteins, Gene)FDA Link
08/2022 - 08/2022
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2021 - 01/2021
2Carboplatin (JM8)FDA LinkGeneric
04/2018 - 02/2016
2Hormones (Hormone)IBA
01/2018 - 12/2013
2AndrogensIBA
01/2018 - 12/2013
2enzalutamideIBA
01/2018 - 12/2015
1Antineoplastic Agents (Antineoplastics)IBA
01/2024
1Cytotoxins (Cytolysins)IBA
01/2024
1pralsetinibIBA
12/2023
1N 30IBA
12/2023
1patritumab deruxtecanIBA
12/2023
1Letrozole (Femara)FDA LinkGeneric
10/2023
1Estrogen ReceptorsIBA
10/2023
1Aromatase InhibitorsIBA
10/2023
1Estradiol (Delestrogen)FDA LinkGeneric
10/2023
1Colloids (Colloid)IBA
05/2023
1Circular RNAIBA
05/2023
1RNA (Ribonucleic Acid)IBA
05/2023
1Cell-Free Nucleic AcidsIBA
05/2023
1Proto-Oncogene Proteins c-metIBA
02/2023
1COVID-19 VaccinesIBA
01/2023
1BNT162 VaccineIBA
01/2023
1AntibodiesIBA
01/2023
1Opioid Analgesics (Opioids)IBA
12/2022
1MicroRNAs (MicroRNA)IBA
08/2022
1Codon (Codons)IBA
05/2022
1Thioredoxin-Disulfide ReductaseIBA
05/2022
1defactinibIBA
05/2022
1pevonedistatIBA
02/2022
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2022
1PM 01183IBA
05/2021
1InterferonsIBA
01/2021
11-methyl-1-piperidinomethane sulfonateIBA
01/2021
1durvalumabIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Circulating Tumor DNAIBA
12/2020
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2019
1MucinsIBA
01/2019

Therapy/Procedure

16Immunotherapy
04/2024 - 12/2018
16Therapeutics
01/2024 - 07/2012
14Drug Therapy (Chemotherapy)
01/2024 - 04/2012
2Radiotherapy
09/2023 - 07/2012
2Castration
01/2018 - 12/2015
1Duration of Therapy
01/2024
1Molecular Targeted Therapy
04/2023
1Nutritional Support (Artificial Feeding)
01/2022
1Combination Drug Therapy (Combination Chemotherapy)
08/2019